MANNITOL INJECTION USP DIN 00038024
Health Canada record
| Active ingredient(s) | MANNITOL 25 % |
|---|---|
| Dosage form | Solution |
| Route | Intravenous |
| Schedule | ETHICAL |
| Class | Human |
| ATC | B05BC01 MANNITOL |
| Original market date | 31-Dec-1970 |
| Current status date | 10-Nov-2017 |
| Source | Health Canada DPD |
Establishment licence of the holder
Pfizer Canada ULC — licence 100255, currently licensed, last inspection rating C (2023-08-07).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing MANNITOL
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02489562 | ARIDOL | PHARMAXIS EUROPE LIMITED | Kit; Powder | MANNITOL 20 MG; MANNITOL 40 MG; MANNITOL 5 MG; MANNITOL 10 MG | Marketed |
| 00038016 | MANNITOL INJECTION USP | ICU MEDICAL CANADA INC | Solution | MANNITOL 20 % | Marketed |
| 02243176 | MANNITOL INJECTION, USP | FRESENIUS KABI CANADA LTD | Solution | MANNITOL 25 % | Marketed |
| 00060410 | OSMITROL INJECTION 10% | BAXTER CORPORATION | Solution | MANNITOL 10 % | Marketed |
| 00060437 | OSMITROL INJECTION 20% | BAXTER CORPORATION | Solution | MANNITOL 20 % | Marketed |
| 00037990 | MANNITOL INJ 10% ABBOVAC | ABBOTT LABORATORIES, LIMITED | Liquid | MANNITOL 100 MG | Cancelled Post Market |
| 00243809 | MANNITOL INJ 25% | INTERNATIONAL MEDICATION SYSTEMS LTD. | Liquid | MANNITOL 250 MG | Cancelled Post Market |
| 00729183 | MANNITOL INJ 25% | ASTRA PHARMA INC. | Liquid | MANNITOL 250 MG | Cancelled Post Market |
| 00037982 | MANNITOL INJ 5% ABBOVAC | ABBOTT LABORATORIES, LIMITED | Liquid | MANNITOL 50 MG | Cancelled Post Market |
| 01963953 | RESECTISOL (5% MANNITOL IRRIGATION) | B. BRAUN MEDICAL INC | Liquid | MANNITOL 5 % | Cancelled Post Market |
International API supply for MANNITOL
1 valid EDQM Certificates of Suitability from 1 holders. 20 active FDA Drug Master Files.
Request a quote for MANNITOL INJECTION USP